Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Clinical Study On Ephedra-Free Super CitriMax - Nutraceuticals World

What are you searching for?

Sign in
Research

Clinical Study On Ephedra-Free Super CitriMax

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Results of the Super CitriMax® human clinical study conducted by researchers at Georgetown University Medical Center and Andhra University in India, have been published in Nutrition Research (24(1): 45-58, 2004). Super CitriMax, a patent-pending form of (-)hydroxycitric acid (HCA), is a proprietary, ephedra-free weight loss ingredient developed by InterHealth Nutraceuticals. The new study explored the use of higher doses and a more bioavailable form of HCA bound to calcium and potassium. According to the company, patients in the study not only experienced significant weight loss, but increased fat burning, lowered cholesterol, increased beneficial HDL cholesterol and decreased body mass index (BMI), an indicator of obesity health risk. The eight-week, randomized, double-blind, placebo-controlled human clinical trial also revealed that Super CitriMax significantly increased serum serotonin levels and lowered serum leptin levels, a biomarker of the gene that regulates obesity.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters